Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Checkpoint Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CKPT.
You can purchase shares of Checkpoint Therapeutics (NASDAQ:CKPT) through any online brokerage.
Other companies in Checkpoint Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).
Checkpoint Therapeutics has a consensus price target of $21.00.
The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $3.9798 last updated April 11, 2025 at 6:54 PM EDT.
There are no upcoming dividends for Checkpoint Therapeutics.
Checkpoint Therapeutics’s Q1 earnings are confirmed for Friday, May 9, 2025.
There is no upcoming split for Checkpoint Therapeutics.
Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.